68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

NCT06155994 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: 68Ga-DOTA-MGS5

Sponsor

Medical University Innsbruck

Collaborators

[object Object]